Literature DB >> 1171020

The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system.

B Costall, R J Naylor.   

Abstract

The intracerebral injection technique was used to apply dopamine directly into dopamine-containing areas of the mesolimbic system, the nucleus accumbens septi, tuberculum olfactorium and nucleus amygdaloideus centralis. 200 mug dopamine injected bilaterally into the nucleus accumbens septi caused a stereotyped sniffing behaviour and hyperactivity but only a periodic hyperactivity developed after similar injections into the tuberculum olfactorium and no change in behaviour was observed following injections into the nucleus amygdaloideus centralis. After pretreatment with nialamide, the effects of intracerebral dopamine were enhanced, doses of 1-50 mug dopamine causing consistent stereotyped sniffing and a dose-dependent hyperactivity on injection into the nucleus accumbens septi or tuberculum olfactorium. The effects initiated from the nucleus accumbens septi were most marked. In addition, 50-100 mug dopamine injected into the tuberculum olfactorium caused a periodic biting behaviour. Biting was not observed after injections into the nucleus accumbens septi and, even in the presence of nialamide, injections of dopamine into the nucleus amygdaloideus centralis failed to cause any change in motor behaviour.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171020     DOI: 10.1016/0014-2999(75)90326-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.

Authors:  H Wachtel; S Ahlenius; N E Andén
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

Review 2.  A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  Biphasic changes in motor behaviour following morphine injection into the nucleus accumbens [proceedings].

Authors:  B Costall; D H Fortune; R J Naylor
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

4.  Further aspects of nomifensine pharmacology.

Authors:  B Costall; R J Naylor
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 5.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

Review 6.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Disinhibition of the Nucleus Accumbens Leads to Macro-Scale Hyperactivity Consisting of Micro-Scale Behavioral Segments Encoded by Striatal Activity.

Authors:  Dorin Yael; Orel Tahary; Boris Gurovich; Katya Belelovsky; Izhar Bar-Gad
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

8.  Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives.

Authors:  B Costall; R J Naylor; R M Pinder
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

9.  Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat.

Authors:  C J Pycock; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

10.  Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.

Authors:  C Köhler; L Haglund; S O Ogren; T Angeby
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.